2024 International Congress » Parkinson's Disease: Cognitive functions

“This Abstract Presents the Most Important Scientific ___.” A New Sentence Completion Test for Parkinson’s Disease.

T. Turner, F. Rodriguez-Porcel (Charleston, USA)

A Systematic Review of Transcranial Magnetic Stimulation Clinical Trials in Parkinson’s Disease Patients with Mild Cognitive Impairment

S. Baveja, R. Rajmohan, N. Phielipp (Orange, USA)

Abnormal Top-down Perceptual Modulation Drives Visual Hallucinations in Parkinson’s Disease

A. Cucca, M. Catalan, M. Liccari, TMI. Lombardo, V. Cenacchi, S. Rangan, CV. Manara, S. Mingolo, M. Murgia, T. Agostini, P. Manganotti (Trieste, Italy)

Apathy produces selective deficits in cognitive function when controlling for depression in patients with Parkinson’s disease

G. Badwal, K. Patel, S. Pasternak, H. Ganjavi, R. Renwick, R. Camicioli, K. van Hedger, P. Macdonald (London, Canada)

Assessing the Impact of Deep Brain Stimulation on Cognitive Impairment in Parkinson’s Disease: a longitudinal study.

K. Velázquez-Román, G. Rivera-Monroy, R. Baños-Betancourt, W. Moguel-Cardín, A. Guerra-Anzaldo, C. álvarez-Hernández, A. Domínguez-García, A. Hernández-Medrano, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico city, Mexico)

Assessment of cognitive impairment in Parkinson’s disease in under-represented ethnic groups-The London-Dhaka Parkinson’s Cognitive Study

T. Zannat, KC. Dey, A. Zirra, A. Haque, E. Camboe, D. Mair, T. Haque, S. Waters, CR. Marshall, RS. Weil, S. Ali, N. Mukadam, AJ. Noyce, A. Habib (Dhaka, Bangladesh)

Association between Parkinsonism, Parkinson’s Disease and Cognitive Impairment and Incidence of Dementia in People with Parkinsonism and Parkinson’s Disease in Latin America: A 10/66 Dementia Research Group Study

N. Khan, M. Arruabarrena, D. Kim, M. Jiang, J. Llibre-Rodriguez, A. Salgado, I. Acosta, A. Sosa, D. Acosta, I. Jimenez-Velasquez, M. Guerra, A. Salas, L. Contreras, H. Hesse, C. Tanner, M. Prina, J. Guerra (Newcasle Upon Tyne, United Kingdom)

Attention/Working memory and Executive Tests in Parkinson’s disease: Review, Critique and Recommendations

R. Biundo, O. Bezdicek, D. Cammisuli, B. Cholerton, JC. Dalrymple-Alford, N. Edelstyn, E. Fiorenzato, E. Holker, SI. Martinez-Horta, A. Martini, G. Santangelo, B. Segura, C. Siri, A. Troster, M. Skorvanek, D. Weintraub, G. Geurtsen (Padova, Italy)

Blood Pressure Profile of PD-MCI and PDD in Parkinson’s Disease Patients at Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia

A. Al Jody, A. Tiksnadi, D. Tunjungsari (Jakarta, Indonesia)

Characterisation and longitudinal significance of subjective cognitive decline in GBA and LRRK2 Parkinson’s disease

L. Batzu, D. Urso, S. Rota, A. Podlewska, MA. Qamar, KR. Chaudhuri (London, United Kingdom)

Cleaved plasma kininogen is associated with unfavorable cognitive outcome in Parkinson’s disease

I. Markaki, T. Ntetsika, W. Paslawski, P. Tsitsi, S. Carvalho, JC. Corvol, P. Svenningsson (Stockholm, Sweden)

Clinical and Neuroimaging Biomarker Predictors of Cognitive Dysfunction In Parkinson’s Disease: A Study Using PPMI Data

M. Schlindwein, A. Franco, J. Catao, D. Teixeira-Dos-Santos, A. Bieger, T. Hugentobler Schlickmann, L. Angi Souza, C. Mattjie, F. Suzuki, G. Magalhães Pereira, L. Silveira Kupssinskü, L. Vinícius Moura, R. Ravazio, S. Duarte Pinto, M. Bastiani, R. Barros, E. R. Zimmer, A. Schuh (Porto Alegre, Brazil)

Clinical and neurological features of the course of Parkinsonism disease in patients with CKD with cystatin C disorder

S. Khudayarova, G. Rakhmatullayeva (Tashkent, Uzbekistan)

Cognitive function of patients with Parkinson´s Disease after Deep Brain Stimulation: a gene- and variant-based approach

E. Asimakidou, G. Xiromerisiou, C. Sidiropoulos (Cambridge, United Kingdom)

Cognitive Impairment in a Cohort of Patients with DBS for parkinson’s disease treatment from a multicentric Cohort in Colombia

T. Lopez Gonzalez, S. Poveda, M. Fonseca, P. Arango, O. Rojas, G. Monsalve, J. Diez, J. Lobato, O. Bernal Pacheco (Bogota, Colombia)

Cognitive Performance in Early Neuronal alpha-Synuclein Disease

D. Weintraub, M. Brumm, A. Nair, M. York, R. Dobkin, K. Marek, C. Tanner, T. Simuni, A. Siderowf, D. Galasko, L. Chahine, C. Coffey, K. Merchant, K. Poston, T. Foroud, B. Mollenhauer, E. Brown, K. Kieburtz, M. Frasier, T. Sherer, S. Chowdhury, R. Alcalay, A. Videnovic (Ardmore, USA)

Cognitive profile of Parkinson’s disease (PD) in the Framingham Heart Study (FHS)

A. Gurnani, J. Dookhy, Y. Liu, Y. Li, S. O'Shea, S. Frank, R. Au, J. Mez, T. Alvin Ang, L. Shih (Framingham, USA)

Cognitive Reserve and Motor Subtypes of Parkinson’s Disease

A. Deleón Pérez, S. Castillo Torres, J. Trejo Ayala, I. Estrada Bellmann, B. Chávez Luévanos, P. Téllez Hernández, D. Ortiz Zacarias (Monterrey, Mexico)

Cognitive Reserve may influence Executive Function in Parkinson’s Disease.

J. Trejo-Ayala, P. Téllez-Hernández, S. Castillo-Torres, D. Ortiz-Zacarias, A. de León-Pérez, B. Chávez-Luevanos, I. Estrada-Bellmann (Monterrey, Mexico)

Cognitive status in patients with akinetic-rigid and tremor-dominant forms of Parkinson’s disease in Tajikistan.

M. Mirqosimova (Dushanbe, Tajikistan)

Cognitive, Non-Motor, and Quality of Life Outcomes After STN or GPi DBS for Parkinson’s Disease: An Interim Report from the ADROIT NAPA Sub-Study

M. Potter-Nerger, A. Gharabaghi, C. Torres Diaz, A. Schnitzler, S. Chen, L. Himes, M. Frassica, D. Nanduri, S. Groppa (Hamburg, Germany)

Correlation Between Mild Cognitive Impairment and Levodopa Induced Dyskinesia in Parkinson’s Disease Patients

A. Mansour, A. Radwan, S. Ibrahim, N. Elkhayat (Cairo, Egypt)

Creation and Performance of a Cognitive Summary Score in de novo Parkinson’s Disease: Results from the PPMI Study

M. Brumm, R. Kurth, M. York, D. Weintraub ()

Critically Evaluating Best Practice Guidelines for Cognitive Impairment in Parkinson’s Disease: A Systematic Review (PDCogniCare)

D. Pourzinal, D. Bailey, J. Yang, L. Mitchell, N. Pachana, D. Brooks, SA. Keramat, K. Shrubsole, J. Liddle, H. Tinson, S. Naismith, A. Lehn, R. Marsh, N. Dissanayaka (HERSTON, Australia)

Detecting Mild Cognitive Impairment in Parkinson’s Disease using Speech Markers

K. Smith, J. Williamson, T. Quatieri (Worcester, USA)

Developing a Supervised Machine Learning Model for Long-Term Cognitive Status Prediction in Parkinson Disease

L. Saadatpour, A. Vijayakumari, D. Floden, H. Fernandez, B. Walter (Cleveland, USA)

Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) on Activities of Daily Living, Behavioural and Cognitive ability (A-B-C) of PD Patients: A Randomized Controlled Trial

R. Makkar, R. Hazrati, A. Nehra (Ghaziabad, India)

Evaluating Cognitive Status in Parkinson’s Disease Using a Software-based Eye-Tracking Platform: Preliminary Results of the PALOMA Clinical Trial

M. Tosin, C. Goetz, R. Armstrong, C. Januario, B. Balint, P. Mir (Chicago, USA)

Evidence of basal ganglia involvement in mask-induced inhibition

P. Daye, A. Sangaré, B. Gaymard, P. Pouget (Ottignies-Louvain-la-Neuve, Belgium)

Frontal dysfunction as a cognitive biomarker in prodromal Parkinson’s disease

SJM. Jesús Maestre, LMD. Muñoz Delgado, ACG. Castellano Guerrero, MSE. San Eufrasio, AAG. Adarmes Gómez, DMG. Macías García, PFR. Franco Rosado, BV. Villarreal, BB. Benitez, CPC. Perez Calvo, FCG. Carrillo García, JMR. Martín Rodríguez, PMR. Mir Rivera (SEVILLA, Spain)

How Does Mild Cognitive Impairment in Parkinson’s Disease Affect Communication Abilities?

F. Rodriguez-Porcel, T. Turner (Charleston, USA)

Impact of Cognitive Impairment on Mobility and Linguistic Metrics During a Dual-task in PD

K. Smith, D. Martini (Worcester, USA)

Incident & Prevalent Dementia in Individuals with Parkinson’s Disease in the Framingham Heart Study

J. Dookhy, Y. Li, A. Gurnani, S. O'Shea, S. Frank, R. Au, J. Mez, Y. Liu, TFA. Ang, L. Shih (Galway, Ireland)

Influence of the Level of Education on the Change in Cognitive Function in Parkinson´s Disease. A 5-year Follow-up Study.

D. Santos García, T. de Deus, C. Cores, M. íñiguez, L. Samaniego, J. Paz González, S. Jesús, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, I. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, V. Gómez Mayordomo, V. Nogueira, J. Dotor, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, Z. Mendoza, J. Martínez Castrillo, P. Sánchez Alonso, G. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Seijo, C. Valero, R. Alonso Redondo, T. Buongiorno, C. Ordás, P. Martínez Martín, P. Mir, S. Coppadis (A Coruña, Spain)

Investigating Cognitive Impairments in early Parkinson’s disease

K. Patel, K. van Hedger, S. Pasternak, P. Macdonald (London, Canada)

Misdiagnosis of Cognitive Impairment in Parkinson’s disease

F. Rodriguez-Porcel, T. Turner (Charleston, USA)

Neuropsychological Predictors of Cognitive Decline in Parkinson’s Disease: A Systematic Review (PDCogniCare)

D. Pourzinal, K. Sivakumaran, J. Yang, D. Bailey, L. Mitchell, D. Brooks, A. Lehn, J. Liddle, N. Pachana, H. Tinson, K. Shrubsole, N. Dissanayaka (Herston, Australia)

Neuropsychological Tests of Language, Memory, and Visuospatial Function in Parkinson’s Disease: Review, Critique and Recommendations

O. Bezdicek, R. Biundo, D. Cammisuli, B. Cholerton, J. Dalrymple-Alford, N. Edelstyn, E. Fiorenzato, E. Holker, S. Martinez-Horta, A. Martini, G. Santangelo, B. Segura, C. Siri, A. Troster, M. Skorvanek, D. Weintraub, G. Geurtsen (Praha, Czech Republic)

Orthostatic Hypotension is Associated with Worse Verbal Letter Fluency and Lower Neural Efficiency While Upright in Parkinson’s Disease: A Pilot Study

K. Longardner, P. Reddy, K. Izzetoglu, I. Litvan (SAN DIEGO, USA)

Periodic and Aperiodic EEG Correlates of Cognition in Parkinson’s Disease

G. Hall-Mcmaster, N. Slater, K-L. Horne, A. Harris, R. Shoorangiz, T. Anderson, N. Pat, T. Melzer, J. Dalrymple-Alford (Christchurch, New Zealand)

Predicting cognitive phenotypes in de novo Parkinson’s disease: an fMRI data-driven approach.

MI. de Bartolo, A. Ojha, G. Leodori, C. Piervincenzi, G. Vivacqua, S. Pietracupa, M. Costanzo, F. D'Antonio, S. Barbetti, R. Margiotta, G. Bruno, A. Conte, A. Berardelli, G. Fabbrini, P. Pantano, D. Belvisi (Rome, Italy)

SelfCog®: A 15-min Digitized Cognitive Battery To Measure Cognitive Deficit In Parkinson Disease (PD) Patients

J. Montillot, A. Gil-Salcedo, R. Massart, M. Lunven, A. Petit, A. Dormeuil, H. Salhi, A. Bachoud-Lévi, P. Rémy (Créteil, France)

Semantic Memory in Parkinson’s Disease: Linguistic Features and Neural Correlates

F. Toro-Hernández, J. Migeot, N. Marchant, D. Olivares, F. Ferrante, R. González-Gómez, C. González Campo, S. Fittipaldi, G. Rojas-Costa, S. Moguilner, A. Slachevsky, P. Chaná Cuevas, A. Ibáñez, S. Chaigneau, A. García (São Paulo, Brazil)

Spatial Memory and Processing Speed as Cornerstones in Predicting Falls in Parkinson’s Disease

S. Anis, E. Zimmerman, E. Jansen, R. Kaya, H. Fernandez, C. Lopez-Lennon, L. Dibble, A. Rosenfeldt, J. Alberts (Cleveland, USA)

Subthalamic Nucleus Stimulation Modulates Cognitive Theory of Mind in Parkinson’s Disease

HY. Xiao, LQ. Lang, Z. Ye, JJ. Wu (Shanghai, China)

Subtyping Parkinson’s Disease Mild Cognitive Impairment (PD-MCI) by Cholinergic Degeneration

A. Negida, H. Vohra, H. Nawaz, M. Barrett (Henrico, USA)

The Cats-and-Dogs Test Predicts Cognitive Impairment in Parkinson’s Disease in a Diverse Population

KC. Dey, D. Mair, A. Zirra, E. Camboe, T. Zannat, S. Haque, RS. Weil, DA. Gallagher, C. Budu, T. Haque, S. Ali, N. Mukadam, A. Habib, AJ. Noyce, CR. Marshall, S. Waters (London, United Kingdom)

The East London Parkinson Disease Project: updated results from engaging a diverse population in research

A. Zirra, KC. Dey, T. Haque, E. Camboe, A. Ben-Joseph, J. Kahan, B. Huxford, S. Ganesh, C. Edwards, C. Budu, C. Simonet, DA. Gallagher, S. Waters, AJ. Lees, S. Ali, T. Boyle, RS. Weil, N. Mukadam, CR. Marshall, AJ. Noyce (London, United Kingdom)

The impact of cognitive impairment and Alzheimer’s disease neuropathological changes on gait and falls in Parkinson’s disease

J. Parmera, P. Cullinane, S. Wrigley, T. Revesz, Z. Jaunmuktane, T. Warner, E. de Pablo-Fernandez (London, United Kingdom)

The Impact of Parkinson’s Disease on Causal Perception

Z. Rostami, M. Vaziri Pashkam, M. Salari (Tehran, Islamic Republic of Iran)

The Prevalence of Parkinson’s Disease with Dementia in a door to door survey done in a rural district in Hai, Kilimanjaro.

E. Assey, R. Morton, J. Josephat, R. Valecha (Kilimanjaro, United Republic of Tanzania)

To develop and study the efficacy of Telephonic Psychotherapy on the Global Neuropsychological functioning of PD Patients: An RCT

R. Hazrati, R. Makkar, A. Nehra (New Delhi, India)

Walking reduced the risk of Parkinson’s disease dementia: a retrospective longitudinal follow-up study

CY. Wei, PY. Chiu (Changhua County, Taiwan)